1. Renin-Angiotensin Inhibition in Diastolic Heart Failure and Chronic Kidney Disease 
Ali Ahmed, MD, MPH, Michael W. Rich, MD, Michael Zile, MD, Paul W. Sanders, MD, Kanan Patel, MBBS, MPH, Yan Zhang, MS, MSPH, Inmaculada B. Aban, PhD, Thomas E. Love, PhD, Gregg C. Fonarow, MD, Wilbert S. Aronow, MD, Richard M. Allman, MD 
The American Journal of Medicine 
Volume 126, Issue 2, Pages (February 2013)
DOI: /j.amjmed
Copyright © Terms and Conditions

2. Figure 1
Love plots displaying absolute standardized differences for 56 baseline characteristics among older patients with diastolic heart failure and chronic kidney disease receiving versus not receiving discharge prescriptions for angiotensin-converting enzyme inhibitors or angiotensin receptor blockers before and after propensity score matching.
The American Journal of Medicine  , DOI: ( /j.amjmed )
Copyright © Terms and Conditions

3. Figure 2
Kaplan-Meier plot for all-cause mortality in a propensity-matched cohort of older patients with diastolic heart failure and chronic kidney disease receiving and not receiving discharge prescription of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers. ACEI = angiotensin-converting enzyme inhibitor; ARB = angiotensin receptor blocker; CI = confidence interval.
The American Journal of Medicine  , DOI: ( /j.amjmed )
Copyright © Terms and Conditions

4. Figure 3
Association of discharge prescription of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers with all-cause mortality in subgroups of propensity-matched older patients with diastolic heart failure and chronic kidney disease. ACEI = angiotensin-converting enzyme inhibitor; ARB = angiotensin receptor blocker; CI = confidence interval; GFR = glomerular filtration rate.
The American Journal of Medicine  , DOI: ( /j.amjmed )
Copyright © Terms and Conditions